Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
Recruiting
Early Phase 1
Interventional Study
Localized Prostate Carcinoma
Stage IV Prostate Cancer AJCC v8
Locally Recurrent Prostate Carcinoma
Metastatic Prostate Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 220 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread to other parts of the body (localized) or has spread to other places in the body (metastatic) and how vitamin D insufficiency affects the immune system. This study also aims to find out if replacing vitamin D results in normalization of the i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pre-Registration:
* African American males, age \>= 18 years
* Patients with a previous history of localized or metastatic or locally recurrent prostate cancer
* Registration:
* Patients with Vitamin D levels below 30 ng/ml
Exclusion Criteria:
* Pre-Registration:
…
Contacts
Cancer Center Clinical Trials
866-273-4681 or 507-266-4000
CONTACT